Published in Dig Dis Sci on October 01, 2002
Seronegative Herpes simplex Associated Esophagogastric Ulcer after Liver Transplantation. Case Rep Gastroenterol (2008) 0.75
Esophageal ulceration in human immunodeficiency virus infection. Causes, response to therapy, and long-term outcome. Ann Intern Med (1995) 2.82
The causes of esophageal symptoms in human immunodeficiency virus infection. A prospective study of 110 patients. Arch Intern Med (1991) 1.95
Herpes esophagitis: clinical syndrome, endoscopic appearance, and diagnosis in 23 patients. Gastrointest Endosc (1992) 1.86
Herpesvirus infection of the esophagus and other visceral organs in adults. Incidence and clinical significance. Am J Med (1979) 1.48
Persistent immune deficiency in patients with alcoholic hepatitis. Am J Gastroenterol (1990) 1.40
Esophageal infections in immunosuppressed patients after marrow transplantation. Gastroenterology (1985) 1.26
T and B cell function in alcoholic liver disease. J Hepatol (1986) 0.98
Infectious esophagitis. Gastrointest Endosc Clin N Am (1994) 0.95
Herpetic esophagitis. A common cause of esophageal ulceration. Hum Pathol (1974) 0.92
Herpes simplex esophagitis--a study in autopsy series. Am J Clin Pathol (1985) 0.83
Lymphocyte subset alterations in patients with alcoholic hepatitis. J Clin Lab Immunol (1988) 0.82
Severe bleeding from herpes esophagitis. Am J Gastroenterol (1985) 0.81
Herpetic pneumonia in alcoholic hepatitis. JAMA (1971) 0.80
The frequency and significance of human herpetic esophagitis. An autopsy study. Lab Invest (1963) 0.78
Herpes simplex esophagitis: a cause of upper-gastrointestinal bleeding. Dig Dis Sci (1979) 0.78
[Changes in circulating lymphocyte subsets in alcoholic hepatopathies. Respective role of alcohol, hepatocellular insufficiency and malnutrition]. Gastroenterol Clin Biol (1984) 0.77
Herpesvirus infection of the respiratory tract in patients with alcoholic hepatitis. Alcohol Clin Exp Res (1992) 0.76
[Chronic mucocutaneous herpes simplex infection. Occurrence within the scope of liver-induced immunodeficiency]. Hautarzt (1993) 0.75
Alcohol modulation of immune function: clinical and experimental data. Veterans Affairs Cooperative Study Groups 119 and 275. Alcohol Clin Exp Res (1995) 0.75
Primary biliary cirrhosis. Hepatology (2009) 5.35
Features associated with success rate and performance of FibroScan measurements for the diagnosis of cirrhosis in HCV patients: a prospective study of 935 patients. J Hepatol (2006) 3.57
Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease. Liver Int (2009) 3.12
American College of Chest Physicians/La Société de Réanimation de Langue Française statement on competence in critical care ultrasonography. Chest (2009) 3.03
Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology (2004) 2.49
Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis. N Engl J Med (2011) 2.44
Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis. Hepatology (2002) 2.38
Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis. Hepatology (2008) 2.36
Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC. Hepatology (2006) 2.21
Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int (2008) 2.19
Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases. Gut (2012) 2.17
Effect of prolonged interferon therapy on the outcome of hepatitis C virus-related cirrhosis: a randomized trial. Clin Gastroenterol Hepatol (2007) 2.08
A modified international normalized ratio as an effective way of prothrombin time standardization in hepatology. Hepatology (2007) 1.96
Prednisolone with vs without pentoxifylline and survival of patients with severe alcoholic hepatitis: a randomized clinical trial. JAMA (2013) 1.94
Cirrhotic patients in the medical intensive care unit: early prognosis and long-term survival. Crit Care Med (2010) 1.94
Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis. Hepatology (2012) 1.92
Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis. Hepatology (2005) 1.90
Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. J Hepatol (2005) 1.88
Impact of steatosis on progression of fibrosis in patients with mild hepatitis C. Hepatology (2005) 1.85
Early primary biliary cirrhosis: biochemical response to treatment and prediction of long-term outcome. J Hepatol (2011) 1.82
Bile salts control the antimicrobial peptide cathelicidin through nuclear receptors in the human biliary epithelium. Gastroenterology (2008) 1.73
Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound Med Biol (2010) 1.70
Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis. J Hepatol (2003) 1.68
The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis. Gastroenterology (2005) 1.67
Aspects of liver pathology in adult patients with MDR3/ABCB4 gene mutations. Virchows Arch (2012) 1.63
Pleural ultrasound compared with chest radiographic detection of pneumothorax resolution after drainage. Chest (2010) 1.60
Contribution of mrp2 in alterations of canalicular bile formation by the endothelin antagonist bosentan. J Hepatol (2002) 1.59
Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C. Hepatology (2007) 1.58
The myofibroblastic conversion of peribiliary fibrogenic cells distinct from hepatic stellate cells is stimulated by platelet-derived growth factor during liver fibrogenesis. Lab Invest (2003) 1.57
Primary biliary cirrhosis: incidence and predictive factors of cirrhosis development in ursodiol-treated patients. Gastroenterology (2002) 1.56
Emerging severe and fatal infections due to Klebsiella pneumoniae in two university hospitals in France. J Clin Microbiol (2011) 1.52
Improved prognosis of septic shock in patients with cirrhosis: a multicenter study*. Crit Care Med (2014) 1.52
Prognostic scores for cirrhotic patients admitted to an intensive care unit: which consequences for liver transplantation? Clin Res Hepatol Gastroenterol (2013) 1.50
Prognosis of patients aged 80 years and over admitted in medical intensive care unit. Intensive Care Med (2004) 1.49
Pioglitazone as adjuvant therapy in chronic hepatitis C: sequential rather than concomitant administration with pegylated interferon and ribavirin? J Hepatol (2009) 1.48
Prediction of evolution toward brain death upon admission to ICU in comatose patients with spontaneous intracerebral hemorrhage using simple signs. Transpl Int (2013) 1.48
Homeless Patients in the ICU: An Observational Propensity-Matched Cohort Study. Crit Care Med (2015) 1.46
Significance of antibodies to soluble liver antigen/liver pancreas: a large French study. Liver Int (2009) 1.41
Need to strictly define hepatitis B virus immunotolerant patients to avoid unnecessary liver biopsy. Gastroenterology (2008) 1.40
Chronic liver injury during obstructive sleep apnea. Hepatology (2005) 1.39
Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure. Hepatology (2007) 1.33
Impact of IGF-1R/EGFR cross-talks on hepatoma cell sensitivity to gefitinib. Int J Cancer (2006) 1.32
Early change in bilirubin levels is an important prognostic factor in severe alcoholic hepatitis treated with prednisolone. Hepatology (2003) 1.26
Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: A randomized, controlled trial. Hepatology (2008) 1.26
Point-of-care ultrasound in intensive care units: assessment of 1073 procedures in a multicentric, prospective, observational study. Intensive Care Med (2015) 1.22
PET/CT in patients with hepatocellular carcinoma using [(18)F]fluorocholine: preliminary comparison with [(18)F]FDG PET/CT. Eur J Nucl Med Mol Imaging (2006) 1.21
Quality of life in patients with primary biliary cirrhosis. Hepatology (2004) 1.20
ABCB4 gene mutation-associated cholelithiasis in adults. Gastroenterology (2003) 1.18
Low phospholipid associated cholelithiasis: association with mutation in the MDR3/ABCB4 gene. Orphanet J Rare Dis (2007) 1.18
Pentoxifylline does not decrease short-term mortality but does reduce complications in patients with advanced cirrhosis. Gastroenterology (2010) 1.14
Effect of the interaction between steatosis and alcohol intake on liver fibrosis progression in chronic hepatitis C. Am J Gastroenterol (2002) 1.13
Multicenter prospective validation of the Baveno IV and Baveno II/III criteria in cirrhosis patients with variceal bleeding. Hepatology (2015) 1.08
Chronic hepatitis B virus carriers in the immunotolerant phase of infection: histologic findings and outcome. Clin Gastroenterol Hepatol (2007) 1.05
Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Ann Emerg Med (2011) 1.04
Compliance of health care workers to hand hygiene: awareness of being observed is important. Intensive Care Med (2006) 1.04
Results of short-term training of naïve physicians in focused general ultrasonography in an intensive-care unit. Intensive Care Med (2009) 1.04
Protoporphyrin retention in hepatocytes and Kupffer cells prevents sclerosing cholangitis in erythropoietic protoporphyria mouse model. Gastroenterology (2011) 1.03
Demographic, lifestyle, medical and familial factors associated with primary biliary cirrhosis. J Hepatol (2010) 1.01
False elevation of blood lactate reveals ethylene glycol poisoning. Am J Emerg Med (2009) 0.97
Klebsiella pneumoniae liver abscesses. Lancet Infect Dis (2013) 0.97
Disease activity and cancer risk in inflammatory bowel disease associated with primary sclerosing cholangitis. World J Gastroenterol (2008) 0.96
Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Am J Gastroenterol (2006) 0.96
Clinicopathological forms and prognostic index in Budd-Chiari syndrome. J Hepatol (2003) 0.94
Sonography as an alternative to radiography for nasogastric feeding tube location. Intensive Care Med (2005) 0.94
Improvement in the prognosis of cirrhotic patients admitted to an intensive care unit, a retrospective study. Eur J Gastroenterol Hepatol (2012) 0.93
Pneumocystis jirovecii pneumonia in patients with or without AIDS, France. Emerg Infect Dis (2014) 0.92
Carbofuran poisoning detected by mass spectrometry of butyrylcholinesterase adduct in human serum. J Appl Toxicol (2009) 0.92
Novel mutations in the Dubin-Johnson syndrome gene ABCC2/MRP2 and associated biochemical changes. Ann Clin Biochem (2012) 0.92
Vascular involvement of the liver in Turner's syndrome. Hepatology (2004) 0.91
[Drug-induced liver injury; fourteenth updated edition of the bibliographic database of liver injuries and related drugs]. Gastroenterol Clin Biol (2005) 0.90
Acid-base problems in diabetic ketoacidosis. N Engl J Med (2015) 0.90
Hepatocyte growth factor and c-Met inhibition by hepatic cell hypoxia: a potential mechanism for liver regeneration failure in experimental cirrhosis. Am J Pathol (2002) 0.90
Genetic and acquired thrombotic factors in chronic hepatitis C. Am J Gastroenterol (2004) 0.88
Post-mortem CT scan with contrast injection and chest compression to diagnose pulmonary embolism. Intensive Care Med (2014) 0.87
High prevalence of infectious events in thrombotic thrombocytopenic purpura and genetic relationship with toll-like receptor 9 polymorphisms: experience of the French Thrombotic Microangiopathies Reference Center. Transfusion (2013) 0.87
Association between ABO blood group and fibrosis severity in chronic hepatitis C infection. Dig Dis Sci (2006) 0.87
Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: a prospective magnetic resonance imaging and histological study. Hepatology (2009) 0.87
Beta-blockers have no effect on outcomes in patients with cirrhosis and severe infections. Hepatology (2011) 0.87
An integrated approach for prescribing fewer chest x-rays in the ICU. Ann Intensive Care (2011) 0.87
Community-acquired pneumonia. N Engl J Med (2015) 0.87
Evaluation of blind nasotracheal suctioning and non-bronchoscopic mini-bronchoalveolar lavage in critically ill patients with infectious pneumonia: a preliminary study. Respir Care (2013) 0.87
Ursodeoxycholic acid therapy and the risk of colorectal adenoma in patients with primary biliary cirrhosis: an observational study. Hepatology (2003) 0.87
Smoking as an independent risk factor of liver fibrosis in primary biliary cirrhosis. J Hepatol (2011) 0.86
Bone loss in primary biliary cirrhosis: absence of association with severity of liver disease. Joint Bone Spine (2002) 0.86
Colorimetric capnography, a new procedure to ensure correct feeding tube placement in the intensive care unit: an evaluation of a local protocol. J Crit Care (2010) 0.86
Schizocytosis in pernicious anemia mimicking thrombotic thrombocytopenic purpura. Am J Med (2003) 0.86
Factor V Leiden as a risk factor for cirrhosis in chronic hepatitis C. Hepatology (2004) 0.86
Colorimetric capnography to ensure correct nasogastric tube position. J Crit Care (2008) 0.86
Percutaneous acetic acid injection for hepatocellular carcinoma: using CT fluoroscopy to evaluate distribution of acetic acid mixed with an iodinated contrast agent. AJR Am J Roentgenol (2003) 0.85
Invasive infections due to Candida norvegensis and Candida inconspicua: report of 12 cases and review of the literature. Med Mycol (2013) 0.85
Osmolar gap hyponatremia in critically ill patients: evidence for the sick cell syndrome? Crit Care Med (2002) 0.85
Biochemical markers of liver fibrosis and lymphocytic piecemeal necrosis in UDCA-treated patients with primary biliary cirrhosis. Liver Int (2004) 0.85
Variation in natriuretic peptides and mitral flow indexes during successful ventilatory weaning: a preliminary study. Intensive Care Med (2007) 0.85
Pregnancy in women with ursodeoxycholic acid-treated primary biliary cirrhosis. J Hepatol (2005) 0.84
Identification of a novel 974C-->G nonsense mutation of the MRP2/ABCC2 gene in a patient with Dubin-Johnson syndrome and analysis of the effects of rifampicin and ursodeoxycholic acid on serum bilirubin and bile acids. Am J Gastroenterol (2006) 0.84
ABCB4 gene mutations and primary sclerosing cholangitis. Gastroenterology (2004) 0.84